Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value ($000): $132,134 (100.0% shares, 0.0% debt)

Holdings (6)

TELA TELA BIO, INC. 31.5%

Value ($000) $41,641 Shares 4,110,709 Est. Cost $11.82 Unrealized -13.4%

BVS BIOVENTUS 28.5%

Value ($000) $37,632 Shares 13,021,324 Est. Cost $13.37 Unrealized -85.6%

EYPT EYEPOINT PHARMACEUTICALS INC 27.6%

Value ($000) $36,461 Shares 4,190,921 Est. Cost $4.68 Unrealized +30.5%

— REVANCE THERAPEUTICS INC 8.8%

Value ($000) $11,569 Shares 457,085 Est. Cost $31.50 Unrealized —

MNOV MEDICINOVA INC 1.9%

Value ($000) $2,544 Shares 1,105,941 Est. Cost $2.95 Unrealized -25.3%

— VENUS CONCEPT, INC. 1.7%

Value ($000) $2,287 Shares 1,089,190 Est. Cost $2.12 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
TELA	TELA BIO, INC.	4,110,709	$41,641	31.5%	$11.82	-13.4%	COM	872381108
BVS	BIOVENTUS	13,021,324	$37,632	28.5%	$13.37	-85.6%	COM CL A	09075A108
EYPT	EYEPOINT PHARMACEUTICALS INC	4,190,921	$36,461	27.6%	$4.68	+30.5%	COM NEW	30233G209
—	REVANCE THERAPEUTICS INC	457,085	$11,569	8.8%	$31.50	—	COM	761330109
MNOV	MEDICINOVA INC	1,105,941	$2,544	1.9%	$2.95	-25.3%	COM NEW	58468P206
—	VENUS CONCEPT, INC.	1,089,190	$2,287	1.7%	$2.12	—	COM	92332W105